Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Rhythm Biosciences stock price, quote, forecast and news

RHY.AX
AU000000RHY2
A2H8M4

Price

0.06
Today +/-
+0
Today %
+0 %
P

Rhythm Biosciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Rhythm Biosciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Rhythm Biosciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Rhythm Biosciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Rhythm Biosciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Rhythm Biosciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Rhythm Biosciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Rhythm Biosciences’s growth potential.

Rhythm Biosciences Revenue, EBIT and net profit per share

DateRhythm Biosciences RevenueRhythm Biosciences EBITRhythm Biosciences Net Income
2023228,270 undefined-11.3 M undefined-8.22 M undefined
202224,970 undefined-11.21 M undefined-8.79 M undefined
202113,970 undefined-7.72 M undefined-6.61 M undefined
202046,270 undefined-4.12 M undefined-4.02 M undefined
2019141,070 undefined-3.57 M undefined-2.55 M undefined
201864,480 undefined-1.56 M undefined-1.75 M undefined
20170 undefined-72,130 undefined-72,130 undefined

Rhythm Biosciences Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2017201820192020202120222023
0000000
-------
-------
00-1-1-200
0-1-3-4-7-11-11
-------
0-1-2-4-6-8-8
--100.00100.0050.0033.33-
115.4689.3115.46101.02189.7214.45221.55
-------
Details

Keystats

ⓘ

Revenue and Growth

The Rhythm Biosciences Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Rhythm Biosciences is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Rhythm Biosciences provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Rhythm Biosciences's financial health and stability.

Assets

Rhythm Biosciences's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Rhythm Biosciences must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Rhythm Biosciences after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Rhythm Biosciences's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2017201820192020202120222023
0000000
0000000
0000000
0000123
0000000
0000000
0000000
0-1-2-2-5-6-6
0000000
0000000
0000000
0000000
0000000
19006123
18005113
-------
0000000
14-6-6-6-3-13
-0-1.96-3.05-2.79-5.47-6.52-7.06
0000000

Rhythm Biosciences stock margins

The Rhythm Biosciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Rhythm Biosciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Rhythm Biosciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Rhythm Biosciences's sales revenue. A higher gross margin percentage indicates that the Rhythm Biosciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Rhythm Biosciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Rhythm Biosciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Rhythm Biosciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Rhythm Biosciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Rhythm Biosciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Rhythm Biosciences Margin History

Rhythm Biosciences Gross marginRhythm Biosciences Profit marginRhythm Biosciences EBIT marginRhythm Biosciences Profit margin
2023-143.13 %-4,949.45 %-3,599.93 %
2022-690.35 %-44,877.53 %-35,216.34 %
2021-15,574.81 %-55,257.56 %-47,331.07 %
2020-2,920.96 %-8,893.84 %-8,694.58 %
2019-1,046.9 %-2,533.33 %-1,804.89 %
2018-1,114.25 %-2,425.81 %-2,719.42 %
2017-143.13 %0 %0 %

Rhythm Biosciences Stock Sales Revenue, EBIT, Earnings per Share

The Rhythm Biosciences earnings per share therefore indicates how much revenue Rhythm Biosciences has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Rhythm Biosciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Rhythm Biosciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Rhythm Biosciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Rhythm Biosciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Rhythm Biosciences Revenue, EBIT and net profit per share

DateRhythm Biosciences Sales per ShareRhythm Biosciences EBIT per shareRhythm Biosciences Earnings per Share
20230 undefined-0.05 undefined-0.04 undefined
20220 undefined-0.05 undefined-0.04 undefined
20210 undefined-0.04 undefined-0.03 undefined
20200 undefined-0.04 undefined-0.04 undefined
20190 undefined-0.03 undefined-0.02 undefined
20180 undefined-0.02 undefined-0.02 undefined
20170 undefined-0 undefined-0 undefined

Rhythm Biosciences business model

Rhythm Biosciences is one of the most popular companies on Eulerpool.com.

Rhythm Biosciences historical P/E ratio, EBIT, and P/S ratio.

Rhythm Biosciences shares outstanding

The number of shares was Rhythm Biosciences in 2023 — This indicates how many shares 221.546 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Rhythm Biosciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Rhythm Biosciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Rhythm Biosciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Rhythm Biosciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Rhythm Biosciences.

Rhythm Biosciences list of shareholders

%
Name
Stocks
Change
Date
4.66 % FIL Investment Management (Hong Kong) Limited11,777,709680,2173/21/2024
3.19 % Loumea Investments Pty. Ltd.8,052,520-1,702,9158/11/2023
13.84 % Buttula (Otto Leslie Steven)34,961,39610,850,0003/21/2024
1.71 % Rojo Nero Capital Pty. Ltd.4,323,75152,9168/11/2023
1.45 % Giokir Pty. Ltd.3,661,47008/11/2023
1.31 % Soo (Hsien Michael)3,305,40308/11/2023
0.99 % Commonwealth Scientific & Industrial Research Organisation2,500,00008/11/2023
0.98 % Patterson (Natalie Louise)2,477,08408/11/2023
0.84 % Eddington (Daniel William)2,123,53230,7508/11/2023
0.79 % Rogers (Mark Anthony)2,000,0002,000,0008/11/2023
1
2

Rhythm Biosciences Executives and Management Board

Mr. Otto Buttula
Rhythm Biosciences Executive Chairman of the Board (since 2019)
Compensation 756,781
Dr. Trevor Lockett
Rhythm Biosciences Non-Executive Director (since 2017)
Compensation 419,321
Mr. Louis Panaccio66
Rhythm Biosciences Non-Executive Independent Director
Compensation 93,237
Ms. Susan MacLeman
Rhythm Biosciences Independent Non-Executive Deputy Chair of the Board
Ms. Andrea Steele
Rhythm Biosciences General Counsel, Joint Company Secretary
1
2

Most common questions regarding Rhythm Biosciences

What is the P/E ratio of Rhythm Biosciences 2024?

The P/E ratio cannot be calculated for Rhythm Biosciences at the moment.

What is the P/S ratio of Rhythm Biosciences 2024?

The P/S cannot be calculated for Rhythm Biosciences currently.

What is the AlleAktien quality score of Rhythm Biosciences?

The AlleAktien quality score for Rhythm Biosciences is 3/10.

What is the revenue of Rhythm Biosciences 2024?

The revenue cannot currently be calculated for Rhythm Biosciences.

How high is the profit of Rhythm Biosciences 2024?

The profit cannot currently be calculated for Rhythm Biosciences.

What is the business model of Rhythm Biosciences

No history available for Rhythm Biosciences.

What is the Rhythm Biosciences dividend?

Rhythm Biosciences pays a dividend of 0 AUD distributed over payouts per year.

How often does Rhythm Biosciences pay dividends?

The dividend cannot currently be calculated for Rhythm Biosciences or the company does not pay out a dividend.

What is the Rhythm Biosciences ISIN?

The ISIN of Rhythm Biosciences is AU000000RHY2.

What is the Rhythm Biosciences WKN?

The WKN of Rhythm Biosciences is A2H8M4.

What is the Rhythm Biosciences ticker?

The ticker of Rhythm Biosciences is RHY.AX.

How much dividend does Rhythm Biosciences pay?

Over the past 12 months, Rhythm Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Rhythm Biosciences is expected to pay a dividend of 0 AUD.

What is the dividend yield of Rhythm Biosciences?

The current dividend yield of Rhythm Biosciences is .

When does Rhythm Biosciences pay dividends?

Rhythm Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Rhythm Biosciences?

Rhythm Biosciences paid dividends every year for the past 0 years.

What is the dividend of Rhythm Biosciences?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Rhythm Biosciences located?

Rhythm Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Rhythm Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rhythm Biosciences from 7/26/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 7/26/2024.

When did Rhythm Biosciences pay the last dividend?

The last dividend was paid out on 7/26/2024.

What was the dividend of Rhythm Biosciences in the year 2023?

In the year 2023, Rhythm Biosciences distributed 0 AUD as dividends.

In which currency does Rhythm Biosciences pay out the dividend?

The dividends of Rhythm Biosciences are distributed in AUD.

All fundamentals about Rhythm Biosciences

Our stock analysis for Rhythm Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rhythm Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.